CHEMOMAB THERAPEUTICS LTD. - AMERICAN DEPOSITARY

1.9800

13-2月-25 15:45:00

15 分の遅延

株式

-0.0300

-1.49%

本日の幅

1.9300 - 2.0620

ISIN

N/A

ソース

NASDAQ

Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update

24 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis

18 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024

02 4 2024 06:00:00 提供 Nasdaq GlobeNewswire
Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

25 3 2024 06:06:46 提供 Nasdaq GlobeNewswire

<<
<
1
2
>

同意します NetDania's website uses cookies. By continuing browsing our website, you agree to our クッキー方針, 個人情報保護方針 and 利用規約.